Enhancement of oxaliplatin efficacy and amelioration of intestinal epithelial damage by Lactobacillus rhamnosus GG through modulation of gut microbiota
The combined use of LGG and Oxp offers a promising therapeutic strategy for NSCLC, warranting further investigation into the interplay between probiotics, chemotherapy, and the gut microbiota.
Authors
- Yan Geng (ORCID: https://orcid.org/0000-0001-8861-7686)
- Yilin Ren (ORCID: https://orcid.org/0000-0001-6339-8579)
- Zhenghong Xu (ORCID: https://orcid.org/0000-0003-1340-6838)
- Xiaoyu Shen
- Yalan Ni
- Qingjun You (ORCID: https://orcid.org/0000-0003-1151-8318)
- Rui Li (ORCID: https://orcid.org/0000-0003-2707-327X)
- Deli Yi
- Zijie Zhang
Institutions
- Jiangnan University (CN)
- Sichuan University (CN)
- Wuxi Fourth People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.3389/fmicb.2025.1565880
- Citations
- 2
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- National Natural Science Foundation of China
- Wuxi Health and Family Planning Commission